This article introduces a multi-step preparative purification workflow for synthetic peptides using liquid ...

This important study shows that the Nora virus, a natural Drosophila pathogen that also persistently infects many laboratory fly stocks, infects intestinal stem cells (ISCs), leading to a shorter life ...

Dry suction is noninferior to wet suction in terms of diagnostic accuracy in endoscopic ultrasound–guided fine-needle biopsy ...

The initial container systems will include 0.5 mL, 1 mL long, and 1 mL short syringes, along with 2R vials, all in ready-to-fill formats. Container filling can be performed via peristaltic pump or ...

Otulfi will be available in the U.S. in the following presentations: a 45 mg/0.5 mL and 90 mg/mL single-dose prefilled syringe for injection and a 130 mg/26 mL (5 mg/mL) single dose vial for IV ...

STEQEYMA® (ustekinumab-stba) is Celltrion's biosimilar to STELARA® (ustekinumab), which was launched on March 12, 2025 ...

An anesthesiologist accused of trying to kill his wife on a popular Hawaii hiking trail previously accused her of having an affair, which led to “extreme jealousy,” according ...

The approval covered two doses matching those of omalizumab -- a 75 mg/0.5 mL injection and a 150 mg/mL injection -- both to be administered in single-dose prefilled syringes for subcutaneous use.

Dr. Reddy and Alvotech announce the FDA acceptance of the BLA for their proposed biosimilar candidate of Amgen's Prolia and Xgeva for review.

The fourth pair of denosumab biosimilars, Conexxence and Bomyntra, are expected to launch in the United States in mid 2025, ...

A new non-surgical contraceptive implant is delivered through tiny needles. The long-acting implant was developed by American ...